Search

Search Constraints

You searched for: Author/Creator Bessede, Alban

Search Results

1. 817 DT095895, a selective EP4 receptor antagonist with monotherapy efficacy in syngeneic mouse model(s) and best-in-class properties. (9th November 2020)

2. 817 DT095895, a selective EP4 receptor antagonist with monotherapy efficacy in syngeneic mouse model(s) and best-in-class properties. (9th November 2020)

4. Cabozantinib in patients with advanced Ewing sarcoma or osteosarcoma (CABONE): a multicentre, single-arm, phase 2 trial. Issue 3 (March 2020)

5. Erratum: The kynurenine pathway is activated in human obesity and shifted toward kynurenine monooxygenase activation. Issue 8 (August 2016)

6. Involvement of the kynurenine pathway in the pathogenesis of Parkinson's disease. (August 2017)

8. Regorafenib–avelumab combination in patients with biliary tract cancer (REGOMUNE): a single-arm, open-label, phase II trial. (February 2022)

9. Sustained activation of the Aryl hydrocarbon Receptor transcription factor promotes resistance to BRAF-inhibitors in melanoma. Issue 1 (December 2018)

10. The kynurenine pathway is activated in human obesity and shifted toward kynurenine monooxygenase activation. (8th September 2015)